Literature DB >> 23984021

Clinical Spectrum of Hereditary Spastic Paraplegia in Children: A study of 74 cases.

Roshan Koul1, Fathiya M Al-Murshedi, Faisal M Al-Azri, Ranjit Mani, Rana A Abdelrahim, Vivek Koul, Amna M Alfutaisi.   

Abstract

OBJECTIVES: The aim of the study was to explore the spectrum of hereditary spastic paraplegia (HSP) in children in Oman.
METHODS: This retrospective study was carried out between January 1994 and August 2011 on children with delayed development, gait disorders and motor handicaps, with signs of symmetrical pyramidal tract involvement. A detailed perinatal and family history, including the age of onset of symptoms, was recorded. The children were labelled as having either the pure or complicated form of HSP based on the established diagnostic criteria. In families with more than one affected child, parents and all other siblings were also examined.
RESULTS: Within the study, 74 children from 31 families were diagnosed with HSP. Parental consanguinity was seen in 91% of cases, with 44 children (59.4%) experiencing onset of the disease under one year of age. Complicated HSP was the most common type, seen in 81.1%. Speech involvement, mental retardation, and epilepsy were the most common associated abnormalities. Nonspecific white matter changes and corpus callosum abnormalities were noted in 24.3% of cases on magnetic resonance imaging.
CONCLUSION: The study described clinical features of 74 children with HSP. Autosomal recessive complicated HSP was seen in 81.1% of cases.

Entities:  

Keywords:  Disabled Children; Oman; Spastic Paraplegia, Hereditary; Spastic paraplegia, autosomal recessive

Year:  2013        PMID: 23984021      PMCID: PMC3749020          DOI: 10.12816/0003258

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  38 in total

1.  A study of consanguinity in the Sultanate of Oman.

Authors:  A Rajab; M A Patton
Journal:  Ann Hum Biol       Date:  2000 May-Jun       Impact factor: 1.533

Review 2.  Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.

Authors:  Sara Salinas; Christos Proukakis; Andrew Crosby; Thomas T Warner
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

3.  Hereditary spastic paraparesis with distal muscle wasting, microcephaly, mental retardation, arachnodactyly and tremors: new entity?

Authors:  S Farah; M A Sabry; A F al-Shubaili; J T Anim; J M Hussain; M A Montaser; K M Sharfuddin
Journal:  Clin Neurol Neurosurg       Date:  1997-02       Impact factor: 1.876

4.  Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia.

Authors:  P Hedera; O P Eldevik; P Maly; S Rainier; J K Fink
Journal:  Neuroradiology       Date:  2005-09-06       Impact factor: 2.804

Review 5.  Sensory neuropathy in hereditary spastic paraplegia.

Authors:  W Schady; C M Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

6.  Spectrum of paediatric lysosomal storage disorders in oman.

Authors:  Almundher A Al-Maawali; Surendra N Joshi; Roshan L Koul; Ali A Al-Maawali; Hilal S Al-Sedari; Bader M Al-Amri; Amna M Al-Futaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2012-07-15

7.  Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4.

Authors:  F Sartucci; S Tovani; L Murri; L Sagliocco
Journal:  Brain Res Bull       Date:  2007-07-17       Impact factor: 4.077

8.  CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.

Authors:  Cyril Goizet; Amir Boukhris; Alexandra Durr; Christian Beetz; Jeremy Truchetto; Christelle Tesson; Maria Tsaousidou; Sylvie Forlani; Lucie Guyant-Maréchal; Bertrand Fontaine; João Guimarães; Bertrand Isidor; Olivier Chazouillères; Dominique Wendum; Djamel Grid; Françoise Chevy; Patrick F Chinnery; Paula Coutinho; Jean-Philippe Azulay; Imed Feki; Fanny Mochel; Claude Wolf; Chokri Mhiri; Andrew Crosby; Alexis Brice; Giovanni Stevanin
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

9.  Autosomal recessive spastic paraplegia (SPG45) with mental retardation maps to 10q24.3-q25.1.

Authors:  Umut Dursun; Cigdem Koroglu; Elif Kocasoy Orhan; Sibel Aylin Ugur; Aslihan Tolun
Journal:  Neurogenetics       Date:  2009-05-05       Impact factor: 2.660

10.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.

Authors:  Giovanni Stevanin; Filippo M Santorelli; Hamid Azzedine; Paula Coutinho; Jacques Chomilier; Paola S Denora; Elodie Martin; Anne-Marie Ouvrard-Hernandez; Alessandra Tessa; Naïma Bouslam; Alexander Lossos; Perrine Charles; José L Loureiro; Nizar Elleuch; Christian Confavreux; Vítor T Cruz; Merle Ruberg; Eric Leguern; Djamel Grid; Meriem Tazir; Bertrand Fontaine; Alessandro Filla; Enrico Bertini; Alexandra Durr; Alexis Brice
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

View more
  3 in total

1.  A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.

Authors:  Alexandros A Polymeris; Alessandra Tessa; Katherine Anagnostopoulou; Anna Rubegni; Daniele Galatolo; Argirios Dinopoulos; Artemis D Gika; Sotiris Youroukos; Eleni Skouteli; Filippo M Santorelli; Roser Pons
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

2.  Clinico-Investigative Profile of Hereditary Spastic Paraplegia in Children.

Authors:  Mahesh Kamate; Mayank Detroja
Journal:  Ann Indian Acad Neurol       Date:  2019 Jul-Sep       Impact factor: 1.383

3.  Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias.

Authors:  Gabriela Marchisio Giordani; Fabrício Diniz; Helena Fussiger; Carelis Gonzalez-Salazar; Karina Carvalho Donis; Fernando Freua; Roberta Paiva Magalhães Ortega; Julian Letícia de Freitas; Orlando Graziani Povoas Barsottini; Sergio Rosemberg; Fernando Kok; José Luiz Pedroso; Marcondes Cavalcante França; Jonas Alex Morales Saute
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.